New Delhi News

Global G-CSF (Granulocyte Colony Stimulating Factors) Market Value Expected To Reach $8.33 Billion By 2023

 Breaking News
  • No posts were found

Global G-CSF (Granulocyte Colony Stimulating Factors) Market Value Expected To Reach $8.33 Billion By 2023

October 28
18:24 2020
Global G-CSF (Granulocyte Colony Stimulating Factors)  Market Value Expected To Reach $8.33 Billion By 2023

G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2020-30: COVID-19 Growth And Change
BioCad Is One Of The Largest Players In The G-CSF (Granulocyte Colony Stimulating Factors) Market, According To The Business Research Company’s G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2020-30: COVID-19 Growth And Change

(Companies Covered: BioCad, Teva Pharmaceuticals, Pfizer, Intas Pharmaceuticals, Novartis AG, Stada Arzneimittel, Dong-A Socio Group, Amgen, Dr. Reddy`s Laboratories, Celltrion Inc., Emcure Pharmaceuticals.)

The global Granulocyte-Colony Stimulating Factor (G-CSF) is expected to decline from $7.30 billion in 2019 to $6.91 billion in 2020 at a compound annual growth rate of -5.27%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $8.33 billion in 2023 at a compound annual growth rate of 6.44%.

Read More On The Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report At –
https://www.thebusinessresearchcompany.com/report/g-csf-granulocyte-colony-Stimulating-factors-global-market-report-2020-30-covid-19-growth-and-change

The G-CSF (Granulocyte Colony Stimulating Factors) market consists of sales of G-CSF drugs and relates services. Granulocyte colony-stimulating factor is a drug used to treat neutropenia, a disorder in which there is a lower-than-average number of white blood cells, caused by certain forms of chemotherapy.

Global G-CSF (Granulocyte Colony Stimulating Factors) Market Segmentation –
1) By Type: Lenograstim (Granocyte), Filgrastim (Neupogen, Zarzio, Nivestim, Accofil), Long acting (pegylated) filgrastim (pegfilgrastim, Neulasta, Pelmeg, Ziextenco), Lipegfilgrastim (Lonquex).
2) By Application: Oncological Diseases, Blood Disorders, Growth Hormone Deficiencies, Chronic and Autoimmune Disorders, Others.

Global G-CSF (Granulocyte Colony Stimulating Factors) Market Driver –
The increasing demand for prophylaxis granulocyte colony-stimulating factor (G-CSF) is another key factor driving the growth of the granulocyte-colony stimulating factor market. The prophylaxis with G-CSF decreases the occurrence of febrile neutropenia (FN), allowing patients to receive and stay on myelosuppressive chemotherapy.

Request For A Sample Of The Global G-CSF (Granulocyte Colony Stimulating Factors)  Market Report At –
https://www.thebusinessresearchcompany.com/sample.aspx?id=3466&type=smp

Few Points From The Global G-CSF (Granulocyte Colony Stimulating Factors)  Market TOC
1. Executive Summary
2. G-CSF (Granolocyte Colony Stimulating Factors) Market Characteristics
3. G-CSF (Granolocyte Colony Stimulating Factors) Market Size And Growth
3.1. Global G-CSF (Granolocyte Colony Stimulating Factors) Historic Market, 2015 – 2019, $ Billio
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global G-CSF (Granolocyte Colony Stimulating Factors) Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. G-CSF (Granolocyte Colony Stimulating Factors) Market Segmentation
4.1. Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Type,
Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
4.2. Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Segmentation By Application,
Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. G-CSF (Granolocyte Colony Stimulating Factors) Market Regional And Country Analysis
5.1. Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global G-CSF (Granolocyte Colony Stimulating Factors) Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Media Contact
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
Address:
City: London
State: Greater London
Country: United Kingdom
Website: https://www.thebusinessresearchcompany.com/

Related Articles